January 2011 Issue of MMM
Did you know that in India more human legs are lost each year to diabetes--around 40,000--than are lost to landmines across the entire world? Neither ...
It seems fitting that Novo Nordisk's logo features that blue bull, which is the embodiment of an Egyptian god of science and art but could ...
At a time when many agencies considered it a feat just to keep the lights on, Draftfcb Healthcare brought on about 160 fresh faces, launched ...
Facing patent expiry for its Seroquel antipsychotic in 2012, AstraZeneca won approval for an XR formulation, which won't see generic competition until 2017.
Here's a story you don't hear every day: A blockbuster brand sees its patent challenged by generics makers, who win in court and proceed to ...
As the globally esteemed and influential NEJM approaches its 200th anniversary in 2012, it's more accessible, engaging and relevant than ever before.
As customers continue to demand service and dialogue from manufacturers, the pharmaceutical industry and its agency partners must adapt to a world favoring apps over ...
Close your eyes. Imagine you're listening to someone from the Centers for Medicare and Medicaid Services asking US healthcare providers how to create an entity
Good old aspirin, therapeutic compound derived from willow bark, take a well-deserved bow. Well-publicized cases of aspirin induced bleeding are not the topic du jour.
The FDA stretched out the timing of approvals last year as the safety concerns made it increasingly hard to take a yes-no stand on pipeline ...
Roche detailed its "operational excellence" cost-cutting program in a statement, confirming a total workforce reduction of 4,800 jobs, plus another 1,500 positions being either transferred ...
A federal appeals court has agreed to hear oral arguments about whether the First Amendment protects a sales rep's ability to share information about off-label ...
Featuring news about Bausch & Lomb, Allergan and GlaxoSmithKline
Med Ed Report
Serial, active learning may be the most powerful, but creating a program that promotes performance improvement in a distance-learning setting poses a challenge.
Massachusetts debuted data on payments made by drug and device manufacturers to healthcare providers for educational programs, speaking, consulting and other services.
William Hamman, a pilot who claimed to be a cardiologist, received millions in research fees, grants and salaries over 15 years before a routine background ...
Featuring news about ProPublica, The Alliance for CME, Med-IQ and the ACCME
Medical publisher Sage launched two new titles in its Therapeutic Advances series: Therapeutic Advances in Drug Safety and Therapeutic Advances in Hematology.
The Oncologist, a monthly cancer journal published by AlphaMed Press, launched new mobile applications for the iPhone and iPad.
Featuring news about Quadrant HealthCom, Thomson Reuters, GeneGo and Elsevier
Revenge of the dead trees? If journals begin 2011 like they started off 2010, with an infusion of pharma ad dollars, will their revival draw ...
Pharma advertisers use an array of tactics to gather information about online health seekers in a way that is unfair and deceptive, consumer advocates have ...
Patients taking a medication and looking online for health information tend to avoid pharmaceutical company sites, according to an online survey conducted by Accenture.
Featuring news about Merck, Text4baby, Johnson & Johnson, Physicians Interactive and comScore
I suppose many people think of gout as just another example of the indulgences of the past decade finally catching up with aging Baby Boomers.
Johnson & Johnson's Centocor Ortho Biotech is launching a psoriasis awareness campaign featuring sufferer Jon Lovitz.
Two-thirds of life science company executives use social networking or plan to on behalf of their companies, a recent Deloitte survey said.
A federal appeals court reversed a district court ruling that limited the use of prescriber-identifiable data in Vermont, signaling a victory for plaintiffs IMS Health, ...
Research firm SK&A launched a new web video series to spotlight its healthcare marketing strategies.
Two WPP shops--ghg and digital specialty VML--are collaborating on an answer to Publicis' digi-behemoth Digitas.
Cline, Davis & Mann is beaming CDM Princeton president Kyle Barich back to the New York mothership to serve as director of client services.
Reckitt Benckiser shifted global advertising for Durex to Euro RSCG Life Worldwide, Advertising Age reported.
Featuring news about WPP, Publicis Healthcare Communications Group, Creston PLC, Topin & Associates and Vox Medica
While there has been a flurry of proposals to repeal, change or fix the Affordable Care Act, many stakeholders have come together to repeal the ...
During fiscal year 2010 the federal government won a record $3 billion-plus in fines, forfeitures and related actions against drug firms and other FDA-regulated companies, ...
FDA's chief litigator said he is focusing on corporate chief executives for personal prosecution in cases of flagrant off-label product promotions.
In a recent move a consortium of organizations filed a complaint with the FTC alleging that, "Health marketers are using digital data on consumers to ...
Companies worldwide see the iPad as the latest tool to connect with customers, and the healthcare industry is no exception. However, rather than as a ...
A brand is more than just a symbol, slogan or trade name. It transcends logos and visual identities. Brands establish identity, provide differentiation and, most ...
Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.
- Insurance trade group says new HCV drugs could cost California billions
- FDA advisory panelists describe decision to recommend approval of "female Viagra"
- Five things for pharma marketers to know: Tuesday, July 7
- Curious if you're a finalist in the MM&M Awards? Find out now
- Vertex's Orkambi nabs FDA approval but may face payer backlash
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.